bf/NASDAQ:GRCL_icon.jpeg

NASDAQ:GRCL

Gracell Biotechnologies Inc.

  • Stock

10.25

+0.05%

0.01

USD last updated 29/07 01:40:31

Last Close

10.24

21/02 21:00

Market Cap

989.87M

Beta: −1.83

Volume Today

6.37M

Avg: 131.30K

PE Ratio

−12.25

PFCF: -

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the treatment of multiple myeloma; GC019...Show More

    Earnings

    Earnings per Share (Estimate*)

    -2-1.5-1-0.52019-12-312021-03-092022-03-142023-03-132024-03-11

    Revenue (Estimate*)

    100K200K300K400K2019-12-312021-03-092022-03-142023-03-132024-03-11

    *Estimate based on analyst consensus